Safety results of the enzalutamide expanded access program in the United States and Canada for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel.

Expanded Access ◽

Castration Resistant ◽

Expanded Access Program ◽

Previously Treated ◽

Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program

Expert Opinion on Drug Safety ◽

10.1517/14740338.2014.939583 ◽

2014 ◽

Vol 13 (9) ◽

pp. 1165-1173 ◽

Cited By ~ 19

Author(s):

Daniel Castellano ◽

Luis M Antón Aparicio ◽

Emilio Esteban ◽

Alfredo Sánchez-Hernández ◽

Jose Ramón Germà ◽

...

Keyword(s):

Prostate Cancer ◽

Safety Data ◽

Expanded Access ◽

Castration Resistant ◽

Expanded Access Program ◽

0611 The Safety and Tolerability of Pitolisant in the Treatment of Excessive Daytime Sleepiness and Cataplexy in Adult Patients With Narcolepsy: An Open-Label, Expanded Access Program in the United States

SLEEP ◽

10.1093/sleep/zsz067.609 ◽

2019 ◽

Vol 42 (Supplement_1) ◽

pp. A243-A243 ◽

Cited By ~ 1

Author(s):

Eric D Bauer ◽

Craig W Davis ◽

Albena Patroneva ◽

Jeffrey M Dayno ◽

Michael J Thorpy

Keyword(s):

United States ◽

Excessive Daytime Sleepiness ◽

Daytime Sleepiness ◽

The United States ◽

Adult Patients ◽

Open Label ◽

Expanded Access ◽

Expanded Access Program ◽

Corrigendum to “Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States”

Prostate Cancer ◽

10.1155/2019/3425982 ◽

2019 ◽

Vol 2019 ◽

pp. 1-1

Author(s):

Catherine W. Saltus ◽

Zdravko P. Vassilev ◽

Jihong Zong ◽

Brian Calingaert ◽

Elizabeth B. Andrews ◽

...

Keyword(s):

Prostate Cancer ◽

United States ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

The United States ◽

Second Primary ◽

Castration Resistant ◽

Second Primary Malignancies

Cost Of Metastatic Castration-Resistant Prostate Cancer In The United States

Value in Health ◽

10.1016/j.jval.2013.03.664 ◽

2013 ◽

Vol 16 (3) ◽

pp. A136

Author(s):

T.K. Le ◽

Y. Zhang ◽

T.M. Zyczynski

Keyword(s):

Prostate Cancer ◽

United States ◽

The United States ◽

Castration Resistant

Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United States

Journal of Cystic Fibrosis ◽

10.1016/j.jcf.2015.01.008 ◽

2016 ◽

Vol 15 (1) ◽

pp. 116-122 ◽

Cited By ~ 21

Author(s):

Jennifer Taylor-Cousar ◽

Minoo Niknian ◽

Geoffrey Gilmartin ◽

Joseph M. Pilewski

Keyword(s):

United States ◽

Cystic Fibrosis ◽

The United States ◽

Safety And Efficacy ◽

Expanded Access ◽

Expanded Access Program ◽

The safety and tolerability of pitolisant in the treatment of excessive daytime sleepiness and cataplexy in adult patients with narcolepsy: an open-label, expanded access program in The United States

Sleep Medicine ◽

10.1016/j.sleep.2019.11.077 ◽

2019 ◽

Vol 64 ◽

pp. S27

Author(s):

E. Bauer ◽

C. Davis ◽

A. Patroneva ◽

J. Dayno ◽

M. Thorpy

Keyword(s):

United States ◽

Excessive Daytime Sleepiness ◽

Daytime Sleepiness ◽

The United States ◽

Adult Patients ◽

Open Label ◽

Expanded Access ◽

Expanded Access Program ◽

Estimating the Budget Implications of Radium Ra 223 Dichloride in Castration-Resistant Prostate Cancer Patients with Non-Visceral Bone Metastases Treated in Infusion Centers in the United States

Value in Health ◽

10.1016/j.jval.2013.08.443 ◽

2013 ◽

Vol 16 (7) ◽

pp. A400

Author(s):

R.N. Hansen ◽

B. Seal ◽

L. Wen ◽

A. Valderrama ◽

S.D. Sullivan

Keyword(s):

Prostate Cancer ◽

United States ◽

Bone Metastases ◽

Cancer Patients ◽

The United States ◽

Castration Resistant

Safety of enzalutamide in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel: Expanded access in North America

The Prostate ◽

10.1002/pros.22965 ◽

2015 ◽

Vol 75 (8) ◽

pp. 836-844 ◽

Cited By ~ 12

Author(s):

Anthony M. Joshua ◽

Neal D. Shore ◽

Fred Saad ◽

Kim N. Chi ◽

Carl A. Olsson ◽

...

Keyword(s):

Prostate Cancer ◽

North America ◽

Expanded Access ◽

Castration Resistant ◽

Previously Treated

Cabazitaxel Plus Prednisone (CBZP) in Metastatic Castration-Resistant Prostate Cancer (MCRPC) Patients Previously Treated with Docetaxel (D): Efficacy and Safety Results from Early-Access Program (EAP) Single Site Experience

Annals of Oncology ◽

10.1016/s0923-7534(20)33524-9 ◽

2012 ◽

Vol 23 ◽

pp. ix316-ix317

Author(s):

P. Rescigno ◽

C. D'Aniello ◽

P. Federico ◽

L. Puglia ◽

A. Petremolo ◽

...

Keyword(s):

Prostate Cancer ◽

Single Site ◽

Efficacy And Safety ◽

Early Access ◽

Castration Resistant ◽

Previously Treated ◽

Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2019.12.019 ◽

2020 ◽

Vol 18 (4) ◽

pp. 284-294 ◽

Cited By ~ 9

Author(s):

Daniel J. George ◽

Oliver Sartor ◽

Kurt Miller ◽

Fred Saad ◽

Bertrand Tombal ◽

...

Keyword(s):

Prostate Cancer ◽

United States ◽

Clinical Practice ◽

Real World ◽

The United States ◽

Treatment Patterns ◽

Practice Setting ◽

Castration Resistant ◽

Clinical Practice Setting